Annovis Bio Inc. is a biopharmaceutical company focused on developing novel drug candidates to treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Their innovative approach targets multiple pathways implicated in the underlying processes of these diseases, potentially offering new treatment options for patients.